Thermo Fisher Scientific is trading 3.6% up at $622.35, after rising from the September 1, 2026 close of $600.50; no fresh September 2 company-specific catalyst was identified.

  • The latest announcement, dated September 1, concerned a September 15 Morgan Stanley healthcare conference presentation, which does not clearly explain the pre-market move.
  • Nasdaq futures are down 0.35%, so broader risk sentiment does not clearly explain the gain.
  • Recent bullish earnings and analyst-target updates are earlier context, not a new overnight trigger.